Covered recipient · General Payments record
SAMANTHA DIMEO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2025
$3,034.47
- Reported across 104 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $311.19 | 15 |
| Consulting Fee | $175.00 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | $175.00 | 1 |
| ABBVIE INC. | $91.25 | 5 |
| Neurocrine BioSciences, Inc. | $44.61 | 2 |
| Averitas Pharma Inc. | $25.64 | 1 |
| Grifols USA, LLC | $24.83 | 1 |
| PFIZER INC. | $24.25 | 1 |
| TG THERAPEUTICS, INC. | $22.71 | 1 |
| GENZYME CORPORATION | $21.80 | 1 |
| Biogen, Inc. | $20.73 | 1 |
| Medtronic, Inc. | $19.24 | 1 |
| Teva Pharmaceuticals USA, Inc. | $16.13 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.80 | 02/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203548944 | CMS |
| ABBVIE INC. | $15.43 | 04/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203548950 | CMS |
| ABBVIE INC. | $17.55 | 09/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203548956 | CMS |
| ABBVIE INC. | $14.95 | 11/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203548961 | CMS |
| ABBVIE INC. | $29.52 | 12/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203548967 | CMS |
| Alexion Pharmaceuticals, Inc. | $175.00 | 03/27/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1202919462 | CMS |
| Averitas Pharma Inc. | $25.64 | 11/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248560255 | CMS |
| Biogen, Inc. | $20.73 | 02/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1208465402 | CMS |
| GENZYME CORPORATION | $21.80 | 10/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233613983 | CMS |
| Grifols USA, LLC | $24.83 | 05/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249579140 | CMS |
| Medtronic, Inc. | $19.24 | 04/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1219846295 | CMS |
| Neurocrine BioSciences, Inc. | $22.13 | 08/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242870674 | CMS |
| Neurocrine BioSciences, Inc. | $22.48 | 12/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242868369 | CMS |
| PFIZER INC. | $24.25 | 06/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229373876 | CMS |
| Teva Pharmaceuticals USA, Inc. | $16.13 | 03/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247330855 | CMS |
| TG Therapeutics, Inc. | $22.71 | 08/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1226229719 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.